14460 Clinical Trials in Arizona, Page 1132 of 1446

Hide Studies Not Open or Pending

11320

Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Condition(s):Metastatic Esophageal Adenocarcinoma; Metastatic Esophageal Squamous Cell Carcinoma; Metastatic Gastroesophageal Junction Adenocarcinoma; Recurrent Esophageal Adenocarcinoma; Recurrent Esophageal Carcinoma; Recurrent Esophageal Squamous Cell Carcinoma; Recurrent Gastroesophageal Junction Adenocarcinoma; Stage IV Esophageal Cancer AJCC v7Last Updated:February 15, 2024Active, not recruiting

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.